Trimethoxyarene as a Tag for Reaction Analysis
3
3
= 6.7 Hz, 3 H) ppm. 13C NMR (CDCl3, 50 MHz): δ = 162.7, 161.5,
159.2, 158.9, 149.6, 146.4, 144.6, 131.0, 123.1, 114.7, 111.75, 106.9,
95.8, 90.6, 68.5, 55.8, 55.4, 38.5, 31.7, 29.8, 29.2, 29.0, 26.0, 22.6,
300 MHz): δ = 8.10 (d, J = 8.6 Hz, 2 H), 7.91 (d, J = 7.9 Hz, 1
3
3
H), 7.71 (d, J = 8.2 Hz, 1 H), 7.44 (t, J = 7.6 Hz, 1 H), 7.20 (t,
3J = 7.6 Hz, 1 H), 6.87 (s, 1 H), 6.87 (d, J = 8.6 Hz, 2 H), 3.77 (s,
3
22.4, 14.1 ppm. IR (neat): ν = 2929, 2856, 1603, 1503, 1130 cm–1.
3 H), 3.11 (t, 3J = 7.6 Hz, 2 H), 1.82 (quint, 3J = 7.4 Hz, 2 H),
1.56–1.36 (m, 4 H), 0.95 (t, 3J = 6.9 Hz, 3 H) ppm. 13C NMR
(CDCl3, 75 MHz): δ = 162.1, 160.2, 152.3, 151.7, 145.3, 129.2,
129.0, 127.5, 125.4, 121.2, 119.8, 114.6, 114.0, 102.1, 55.3, 33.1,
˜
HRMS (ESI): calcd. for C31H40N3O4 [M + H]+ 518.3013; found
518.3026.
7-(4-Methoxyphenyl)-5-pentylpyrazolo[1,5-a]pyrimidine (12b): A
solution of 6 (108 mg, 1.3 mmol, 3 equiv.) in CH2Cl2 (1 mL) was
added to a Schlenk tube containing 9b (100 mg, 0.4 mmol, 1 equiv.)
followed by K2CO3 (180 mg, 1.3 mmol, 3 equiv.). CH2Cl2 was evap-
orated by heating the reaction mixture at 65 °C. The reaction mix-
ture was stirred at 65 °C until the end of the reaction (2 d). A satu-
rated aqueous solution of NH4Cl was added and the aqueous layer
was extracted with ethyl acetate. The combined organic layers were
dried with Na2SO4, filtered, and evaporated under reduced pres-
sure. Purification by column chromatography on silica gel (pentane/
diethyl ether, 7:3) afforded the products 12b (107 mg, 83%) and
12bЈ (13 mg, 10%); m.p. 52–54 °C. 1H NMR (CDCl3, 300 MHz): δ
31.4, 25.8, 22.4, 14.0 ppm. IR (neat): ν = 2954, 2934, 2867, 1597,
˜
1574, 1529, 1176 cm–1. HRMS (ESI): calcd. for C22H24N3O [M +
H]+ 346.1914; found 346.1912.
Supporting Information (see footnote on the first page of this arti-
cle): Copies of 1H and 13C NMR spectra of all compounds are
provided.
Acknowledgments
This work was supported by a grant (to M. B. T. T) from NOVA-
LIX (Illkirch, France), who also provided free access to the MS-
APPI spectrometer.
3
3
= 8.10 (d, J = 1.89 Hz, 1 H), 8.04 (d, J = 8.6 Hz, 2 H), 7.07 (d,
3
3J = 8.6 Hz, 2 H), 6.75 (s, 1 H), 6.64 (d, J = 2.2 Hz, 1 H), 3.90 (s,
3 H), 2.85 (t, 3J = 7.7 Hz, 2 H), 1.82 (quint, 3J = 7.5 Hz, 2 H),
1.41–1.38 (m, 4 H), 0.92 (t, 3J = 6.7 Hz, 3 H) ppm. 13C NMR
(CDCl3, 50 MHz): δ = 162.4, 161.4, 149.6, 145.8, 144.3, 130.7,
123.3, 113.8, 106.8, 95.6, 55.3, 38.4, 31.5, 28.7, 22.4, 13.9 ppm. IR
[1] For reviews on high-throughput experimentation, see: a) R. J.
Hendershot, C. M. Snively, J. Lauterbach, Chem. Eur. J. 2005,
11, 806–814; b) J. G. de Vries, A. H. M. de Vries, Eur. J. Org.
Chem. 2003, 799–811; c) M. T. Reetz, Angew. Chem. 2001, 113,
292; Angew. Chem. Int. Ed. 2001, 40, 284–310.
[2] a) M. T. Reetz, M. H. Becker, M. Liebl, A. Fürstner, Angew.
Chem. 2000, 112, 1294; Angew. Chem. Int. Ed. 2000, 39, 1236–
1239; b) A. Holzwarth, H. W. Schmidt, W. F. Maier, Angew.
Chem. 1998, 110, 2788; Angew. Chem. Int. Ed. 1998, 37, 2644–
2647; c) M. T. Reetz, M. H. Becker, K. M. Kühling, A. Holz-
warth, Angew. Chem. 1998, 110, 2792; Angew. Chem. Int. Ed.
1998, 37, 2647–2650; d) S. J. Taylor, J. P. Morken, Science 1998,
280, 267–270.
[3] a) W. G. Lewis, F. G. Magallon, V. V. Fokin, M. G. Finn, J.
Am. Chem. Soc. 2004, 126, 9152–9153; b) F. Tanaka, R. Thayu-
manavan, C. F. Barbas III, J. Am. Chem. Soc. 2003, 125, 8523–
8528; c) S. R. Stauffer, J. F. Hartwig, J. Am. Chem. Soc. 2003,
125, 6977–6985; d) R. Moreira, M. Havranek, D. Sames, J.
Am. Chem. Soc. 2001, 123, 3927–3931; e) F. Badalassi, D.
Wahler, G. Klein, P. Crotti, J. L. Reymond, Angew. Chem. 2000,
112, 4233; Angew. Chem. Int. Ed. 2000, 39, 4067–4070; f) G. T.
Copeland, S. J. Miller, J. Am. Chem. Soc. 1999, 121, 4306–4307.
[4] a) O. Lavastre, J. P. Morken, Angew. Chem. 1999, 111, 3357;
Angew. Chem. Int. Ed. 1999, 38, 3163–3165; b) A. C. Cooper,
L. H. McAlexander, D. H. Lee, M. T. Torres, R. Crabtree, J.
Am. Chem. Soc. 1998, 120, 9971–9972.
[5] a) P. Vicennati, N. Bensel, A. Wagner, C. Créminon, F. Taran,
Angew. Chem. 2005, 117, 7023; Angew. Chem. Int. Ed. 2005,
44, 6863–6866; b) F. Taran, C. Gauchet, B. Mohar, S. Meunier,
A. Valleix, P. Y. Renard, C. Créminon, J. Grassi, A. Wagner,
C. Mioskowski, Angew. Chem. 2002, 114, 132; Angew. Chem.
Int. Ed. 2002, 41, 124–127.
[6] a) C. Market, A. Pfaltz, Angew. Chem. 2004, 116, 2552; Angew.
Chem. Int. Ed. 2004, 43, 2498–2500; b) M. T. Reetz, M. H.
Becker, H. W. Klein, D. Stöckigt, Angew. Chem. 1999, 111,
1872; Angew. Chem. Int. Ed. 1999, 38, 1758–1761; c) J. Guo, J.
Wu, G. Siuzdak, M. G. Finn, Angew. Chem. 1999, 111, 1868;
Angew. Chem. Int. Ed. 1999, 38, 1755–1758; d) J. W. Szewczyk,
R. L. Zuckerman, R. G. Bergman, J. A. Ellman, Angew. Chem.
2001, 113, 222; Angew. Chem. Int. Ed. 2001, 40, 216–219.
[7] A. B. Beeler, S. Su, C. A. Singleton, J. A. Porco Jr., J. Am.
Chem. Soc. 2007, 129, 1413–1419.
[8] a) I. Marchi, S. Rudaz, J. L. Veuthey, Talanta 2009, 78, 1–18;
b) D. B. Robb, Dam, M. W. Blades, Anal. Chim. Acta 2008,
627, 34–49; c) S. J. Bos, S. M. van Leeuwen, U. Karst, Anal.
Bioanal. Chem. 2006, 384, 85–99; d) F. di Lena, E. Quintanilla,
P. Chen, Chem. Commun. 2005, 5757–5759; e) K. A. Hanold,
(neat): ν = 2934, 2872, 2839, 1614, 1540, 1504, 1454, 1270, 1252,
˜
1180, 1162 cm–1. HRMS (ESI): calcd. for C18H22N3O [M + H]+
296.1757; found 296.1756.
5-(4-Methoxyphenyl)-7-pentylpyrazolo[1,5-a]pyrimidine (12bЈ):
Waxy solid. 1H NMR (CDCl3, 400 MHz): δ = 8.11 (d, 3J = 2.4 Hz,
3
1 H), 8.06 (d, J = 8.8 Hz, 2 H), 7.08 (s, 1 H), 7.03 (d, 3J = 8.8 Hz,
3
3
2 H), 6.68 (d, J = 2.4 Hz, 1 H), 6.64 (d, J = 2.2 Hz, 1 H), 3.89 (s
3 H), 3.21 (t, 3J = 7.8 Hz, 2 H), 1.93 (quint, 3J = 7.6 Hz, 2 H),
1.53–1.40 (m, 4 H), 0.94 (t, 3J = 7.2 Hz, 3 H) ppm. 13C NMR
(CDCl3, 100 MHz): δ = 161.5, 155.6, 149.7, 149.1, 144.7, 130.3,
128.9, 114.4, 103.3, 96.6, 55.5, 31.7, 30.8, 25.9, 22.5, 14.1 ppm. IR
(neat): ν = 2953, 2926, 2854, 2872, 1601, 1577, 1551, 1513, 1419,
˜
1377, 1257, 1234, 1172 cm– 1 . HRMS (ESI): calcd. for
C18H22N3O [M + H]+ 296.1757; found 296.1756.
4-Pentyl-2-(4-{[5-(2,4,6-trimethoxyphenyl)pentyl]oxy}phenyl)-
pyrimido[1,2-a]benzimidazole (13a): Orange solid; m.p. 130–132 °C.
3
1H NMR (CDCl3, 300 MHz): δ = 8.18 (d, J = 8.7 Hz, 2 H), 7.96
(d, 3J = 8.1 Hz, 1 H), 7.82 (d, 3J = 8.4 Hz, 1 H), 7.50 (t, 3J =
3
3
7.6 Hz, 1 H), 7.30 (t, J = 7.1 Hz, 1 H), 7.01 (s, 1 H), 6.95 (d, J =
3
9.0 Hz, 2 H), 6.14 (s, 2 H), 3.99 (t, J = 6.5 Hz, 2 H), 3.80 (s, 9 H),
3
3
3.24 (t, J = 7.6 Hz, 2 H), 2.61 (t, J = 7.0 Hz, 2 H), 1.93–1.83 (m,
4 H), 1.60–1.42 (m, 8 H), 0.98 (t, 3J = 7.1 Hz, 3 H) ppm. 13C NMR
(CDCl3, 75 MHz): δ = 162.0, 160.5, 159.2, 158.9, 151.7, 145.5,
129.4, 128.9, 127.6, 125.6, 121.3, 120.1, 114.7, 114.6, 111.6, 102.5,
90.6, 68.4, 55.7, 55.4, 33.3, 31.5, 29.2, 29.1, 26.0, 22.5, 22.4, 14.1
ppm. IR (neat): ν = 2927, 2855, 2837, 1595, 1577, 1134 cm–1.
˜
HRMS (ESI): calcd. for C35H42N3O4 [M + H]+ 568.3170; found
568.3175.
2-(4-Methoxyphenyl)-4-pentylpyrimido[1,2-a]benzimidazole (13b):
Compound 7 (173 mg, 1.3 mmol, 3 equiv.) was added to a solution
of 9b (100 mg, 0.4 mmol, 1 equiv.) in THF/H2O (1:1) (2 mL). The
reaction mixture was stirred at 50 °C until the end of the reaction
(2 d). A saturated aqueous solution of NH4Cl was added and the
aqueous layer was extracted with ethyl acetate. The combined or-
ganic layers were dried with Na2SO4, filtered, and evaporated un-
der reduced pressure. Purification by column chromatography on
silica gel (diethyl ether/dichloromethane, 6:4) afforded 13b as a yel-
low solid (88 mg, 78%); m.p. 136–138 °C. 1H NMR (CDCl3,
Eur. J. Org. Chem. 2012, 85–92
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
91